PRMT3 and breast carcinoma: Mechanistically, PRMT3 regulates the endoplasmic reticulum (ER) stress signalling pathway by promoting asymmetric dimethylation of histone H4 arginine 3 (H4R3me2a), endowing breast cancer cells with robust proliferative and metastatic capabilities [67].